Article
Selective serotonin reuptake inhibitor exposure alters osteoblast gene expression and craniofacial development in mice
12 Oct 2014
Abstract excerpt
BACKGROUND: Selective serotonin reuptake inhibitor (SSRI) use in pregnancy has been linked to craniofacial birth defects. Little is known about the effects of serotonin or SSRIs on craniofacial development. Here, we provide evidence that citalopram (SSRI) alters the osteogenic profile of murine calvarial cells and leads to craniofacial dysmorphology. METHODS: We used mouse calvarial pre-osteoblast cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
